Dexlansoprazole Capsule, Delayed Release
Product Images NDC 50090-5944

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 50090-5944). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dexlansoprazole 01)

FDA Label Image

Figure 1 (Dexlansoprazole 02)

Figure 1 (Dexlansoprazole 02)
This is a graph showing the plasma concentration of Dexlansoprazole at 30mg and 60mg doses over a period of 20 hours. The concentration is measured in ng/mL with values being shown on the y-axis and time in hours on the x-axis.*
FDA Label Image

Label Image (Lbl500905944)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.